Ipamorelin – 10mg | GHRP Research Peptide

Description

Ipamorelin is a selective growth hormone releasing peptide (GHRP) and ghrelin receptor agonist comprising five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH2). It is widely regarded as one of the cleanest and most selective GHRPs in preclinical research, owing to its high specificity for the GH secretagogue receptor (GHS-R) with minimal off-target effects on cortisol, prolactin, or ACTH release — a significant advantage over earlier generation GHRPs such as GHRP-2 and GHRP-6.

Preclinical research has examined ipamorelin’s ability to stimulate pulsatile growth hormone release from the anterior pituitary in a dose-dependent manner. Animal studies have investigated its effects on GH pulse frequency and amplitude, IGF-1 signalling, lean mass accretion models, bone mineral density, and recovery from catabolic states. Its selectivity profile has made ipamorelin a preferred GHRP for researchers seeking clean GH stimulation without confounding hormonal variables.

Ipamorelin is frequently studied in combination with CJC-1295 (without DAC), where GHRH + GHRP co-administration research has demonstrated synergistic amplification of GH release in rodent models. Molecular weight: 711.85 Da. Formula: C38H49N9O5. CAS: 170851-70-4.

Peptryn’s ipamorelin is manufactured to ≥99% purity by HPLC and mass spectrometry. An independent US laboratory COA ships with every batch. Supplied as sterile lyophilized powder. Volume discounts apply from 3 vials.

Storage: Store at -20°C lyophilized. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 28 days.

For laboratory and in vitro research use only. Not intended for human consumption, self-administration, or veterinary use.